Iande Boer SeattleUnited States

• Welcome and introduction
• From evidence to practice: SGLT2 inhibitors as a foundational treatment for patients With CKD
  BeatrizFernandez-Fernandez Speaker bfernandez@fjd.esSpain
• Prompt action in CKD: increasing treatment benefits for your patients with CKD
  Iande Boer Speaker deboer@uw.eduUnited States
• The hidden burden: managing cardiovascular risk in patients with CKD
  BrendonNeuen Speaker bneuen@georgeinstitute.org.auAustralia
• Audience Q&A
• Summary and close